E
Elana J. Bernstein
Researcher at Columbia University
Publications - 69
Citations - 3483
Elana J. Bernstein is an academic researcher from Columbia University. The author has contributed to research in topics: Medicine & Interstitial lung disease. The author has an hindex of 12, co-authored 50 publications receiving 1133 citations. Previous affiliations of Elana J. Bernstein include Hospital for Special Surgery & NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
Post-acute COVID-19 syndrome.
Ani Nalbandian,Kartik Sehgal,Kartik Sehgal,Aakriti Gupta,Aakriti Gupta,Mahesh V. Madhavan,Claire McGroder,Jacob S. Stevens,Joshua R. Cook,Anna S. Nordvig,Daniel Shalev,Tejasav S. Sehrawat,Neha Ahluwalia,Behnood Bikdeli,Donald Dietz,Caroline Der-Nigoghossian,Nadia Liyanage-Don,Gregg F. Rosner,Elana J. Bernstein,Sumit Mohan,Akinpelumi A Beckley,David S. Seres,Toni K. Choueiri,Toni K. Choueiri,Nir Uriel,John C. Ausiello,Domenico Accili,Daniel E. Freedberg,Matthew R. Baldwin,Allan Schwartz,Daniel Brodie,Christine Kim Garcia,Mitchell S.V. Elkind,Jean M. Connors,Jean M. Connors,John P. Bilezikian,Donald W. Landry,Elaine Wan +37 more
TL;DR: A comprehensive review of the current literature on post-acute COVID-19, its pathophysiology and its organ-specific sequelae is provided in this paper, where the authors discuss relevant considerations for the multidisciplinary care of COPD survivors and propose a framework for the identification of those at high risk for COPD and their coordinated management through dedicated COPD clinics.
Journal ArticleDOI
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial
Dinesh Khanna,Cathie Spino,Sindhu R. Johnson,Lorinda Chung,Michael L. Whitfield,Christopher P. Denton,Veronica J. Berrocal,Jennifer M. Franks,Bhavan Mehta,Jerry A. Molitor,Virginia D. Steen,Robert Lafyatis,Robert W. Simms,Anna Gill,Suzanne Kafaja,Tracy M. Frech,Vivien Hsu,Robyn T. Domsic,Janet E. Pope,Jessica K. Gordon,Maureen D. Mayes,Elena Schiopu,Amber Young,Nora Sandorfi,Jane Park,Faye N. Hant,Elana J. Bernstein,Soumya Chatterjee,Flavia V. Castelino,Ali Ajam,Yue Wang,Tammara A. Wood,Yannick Allanore,Marco Matucci-Cerinic,Oliver Distler,Ora Singer,Erica Bush,David A. Fox,Daniel E. Furst +38 more
TL;DR: T cells play a key role in the pathogenesis of early systemic sclerosis and the safety and efficacy of abatacept in patients with diffuse cutaneous systemic sclerosis was assessed.
Journal ArticleDOI
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.
Jessica K. Gordon,Viktor Martyanov,Jennifer M. Franks,Elana J. Bernstein,Jackie Szymonifka,Cynthia M. Magro,Horatio F. Wildman,Tammara A. Wood,Michael L. Whitfield,Robert Spiera +9 more
TL;DR: To assess the safety and efficacy of treatment with belimumab in patients with early diffuse cutaneous systemic sclerosis treated with background mycophenolate mofetil (MMF).
Journal ArticleDOI
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
Brian Skaug,Dinesh Khanna,William R. Swindell,William R. Swindell,Monique Hinchcliff,Tracy M. Frech,Virginia D. Steen,Faye N. Hant,Jessica K. Gordon,Ami A. Shah,Lisha Zhu,W. Jim Zheng,Jeffrey L. Browning,Alexander M.S. Barron,Minghua Wu,Sudha Visvanathan,Patrick Baum,Jennifer M. Franks,Michael L. Whitfield,Victoria K. Shanmugam,Robyn T. Domsic,Flavia V. Castelino,Elana J. Bernstein,Nancy Wareing,Marka A. Lyons,Jun Ying,Julio Charles,Maureen D. Mayes,Shervin Assassi +28 more
TL;DR: Skin in early diffuse SSc has prominent innate and adaptive immune cell signatures that reflect the preceding rate of disease progression, which could have implications in understanding SSc pathogenesis and clinical trial design.
Journal ArticleDOI
Nephrogenic systemic fibrosis: A systemic fibrosing disease resulting from gadolinium exposure
TL;DR: The history, clinical manifestations, epidemiology, histopathology and pathophysiology ofephrogenic systemic fibrosis are reviewed.